Transforming treatment decisions with clinically actionable insights

Now approved for patients in all 50 states, including New York — The Oncology Hotspot assay detects actionable variants in advanced solid tumor cancer to help clinicians personalize and optimize cancer therapy.

• Highly Sensitive
  The power to detect variants down to 5% allele fraction.
• Actionable
  Identifies clinically-actionable variants in 50 genes to help optimize treatment planning.
• Precise
  Analyzes specific variants within 207 regions of the genome known to be associated with cancer diagnosis, prognosis, and treatment response.